Erika P. Berger

Apolipoprotein E is a kinetic but not a thermodynamic inhibitor of amyloid formation: implications for the pathogenesis and treatment of Alzheimer disease.

K C Evans, Erika P. Berger, C G Cho et al. · Proceedings of the National Academy of Sciences · 1995 · 337 citations

Neurodegenerative Diseases, Alzheimer's Disease, Apolipoprotein E +15

Veterinary <scp>Cooperative</scp> Oncology Group—Common Terminology Criteria for Adverse Events (<scp>VCOG‐CTCAE</scp> v2) following investigational therapy in dogs and cats

Amy K. LeBlanc, Matthew J. Atherton, R. Timothy Bentley et al. · Veterinary and Comparative Oncology · 2021 · 296 citations · Full text

Pathology, Veterinary Research, Investigational Therapy +18

Microbiological Criteria of Random Samples of Spices and Herbs Retailed on the Austrian Market

Wolfgang Kneifel, Erika P. Berger · Journal of Food Protection · 1994 · 110 citations · Full text

Food Forensics, Microbiological Criteria, Foodborne Illness +12

Retrospective evaluation of toceranib phosphate (Palladia®) use in the treatment of gastrointestinal stromal tumors of dogs

Erika P. Berger, Chad M. Johannes, Albert E. Jergens et al. · Journal of Veterinary Internal Medicine · 2018 · 54 citations · Full text

Adjuvant Sirolimus Does Not Improve Outcome in Pet Dogs Receiving Standard-of-Care Therapy for Appendicular Osteosarcoma: A Prospective, Randomized Trial of 324 Dogs

Amy K. LeBlanc, Christina Mazcko, Aswini Cherukuri et al. · Clinical Cancer Research · 2021 · 51 citations · Full text